Abstract:Graphical and Lay Summary Two parameters are particularly critical when developing manufacturing cell lines: short timelines and high productivity. This study demonstrates the possibility to concomitantly reduce the timelines by using low viability pools and increase the productivity of the clones by using cold capture, an immunostaining protocol used for two decades. Using Beacon, we validated the positive impact of cold capture on titers and specific productivities. Furthermore, we showed that combining an early sorting with cold capture protocol systematically increased Qp of cells in batch assays. The method developed in this study provides valuable improvement for cell line development workflows. Improving current cell line development workflows can either focus on increasing the specific productivity of the cell lines or shortening timelines to reach the clinic as fast as possible. In this work, using the Beacon platform, we have combined two distinct protocols – early cloning with low‐viability pools, and IgG membrane staining‐, to concomitantly reach both objectives, and generate highly productive CHO clones in shorter timelines. Fast‐sorting approaches using low‐viability pools in combination with the Beacon platform have recently been reported to shorten CLD timelines. However, the low recovery led to a drastic reduction in the clone number obtained postcloning. Here, we report a combined approach of fast‐sorting and fluorescent membrane staining. With this new protocol, the cells reach a correct recovery, allowing to fully exploit the Beacon screening capacities. In addition, by using a fluorescent staining recognizing the secreted IgG, we were able to enrich the fraction of highly secreting cells prior to cloning and we obtained significant increases in the cell's specific productivity. The combination of these two protocols has a synergistic effect, and as they help discarding the dead and nonproducing populations prior to cloning, they increase the throughput power of the Beacon platform and the detection of super productive clones.

Coupling picodroplet microfluidics with plate imaging for the rapid creation of biomanufacturing suitable cell lines with high probability and improved multi-step assurance of monoclonality

Cyto-Mine: An Integrated, Picodroplet System for High-Throughput Single-Cell Analysis, Sorting, Dispensing, and Monoclonality Assurance

Simplifying stable CHO cell line generation with high probability of monoclonality by using microfluidic dispensing as an alternative to fluorescence activated cell sorting

Microfluidic chip‐based single‐cell cloning to accelerate biologic production timelines

A novel mammalian cell line development platform utilizing nanofluidics and optoelectro positioning technology

Assurance of monoclonality in one round of cloning through cell sorting for single cell deposition coupled with high resolution cell imaging

Assuring Clonality on the Beacon Digital Cell Line Development Platform

A single-step FACS sorting strategy in conjunction with fluorescent vital dye imaging efficiently assures clonality of biopharmaceutical production cell lines.

Combined approach of selective and accelerated cloning for microfluidic chip‐based system increases clone specific productivity

High-Throughput, Deterministic Single Cell Trapping and Long-Term Clonal Cell Culture in Microfluidic Devices

An automated high inoculation density fed-batch bioreactor, enabled through N-1 perfusion, accommodates clonal diversity and doubles titers

Methods for Estimating the Probability of Clonality in Cell Line Development

High‐throughput and automation advances for accelerating single‐cell cloning, monoclonality and early phase clone screening steps in mammalian cell line development for biologics production

Openly accessible microfluidic liquid handlers for automated high-throughput nanoliter cell culture.

Automated Nanodroplet Dispensing for Large-Scale Spheroid Generation via Hanging Drop and Parallelized Lossless Spheroid Harvesting

An Integrated Approach toward the Biomanufacturing of Engineered Cell Therapy Products in a Stirred-Suspension Bioreactor

High-throughput combinatorial cell co-culture using microfluidics.

From Chips-in-Lab to Point-of-Care Live Cell Device: Development of a Microfluidic Device for On-Site Cell Culture and High-Throughput Drug Screening

Genomic barcoding for clonal diversity monitoring and control in cell-based complex antibody production

Single‐cell microliter‐droplet screening system (MISS Cell): an integrated platform for automated high‐throughput microbial monoclonal cultivation and picking

Droplet microfluidic technology for single-cell high-throughput screening